Butyrate is the most important short-chain fatty acid (SCFA) for gut health — it's the PRIMARY energy source for colonocytes (cells lining your colon get 70% of their energy from butyrate, not glucose). Your gut bacteria produce it by fermenting dietary fiber. Our research shows butyrate has profound effects: it maintains intestinal barrier integrity (prevents "leaky gut"), has anti-cancer effects in colorectal tissue (paradoxically — it feeds normal colonocytes but kills cancer cells via the "butyrate paradox"), reduces inflammation via HDAC inhibition, and has emerging evidence for brain function via the gut-brain axis. Supplemental butyrate (as sodium/calcium butyrate or tributyrin) can bypass the need for fiber fermentation.
Butyrate's mechanisms: (1) Colonocyte fuel — enters mitochondria via β-oxidation, providing 70% of colonocyte ATP (healthy colonocytes preferentially use butyrate over glucose); (2) HDAC inhibition — butyrate is a class I/II histone deacetylase inhibitor, altering gene expression toward anti-inflammatory, anti-proliferative, and pro-apoptotic programs (this is the anti-cancer mechanism); (3) GPR41/GPR43/GPR109A receptor activation — these SCFA receptors on immune cells, enteroendocrine cells, and neurons mediate immune tolerance (Treg induction), GLP-1/PYY secretion (satiety), and gut-brain signaling; (4) tight junction protein upregulation — increases expression of claudins and occludin, strengthening the intestinal barrier; (5) mucosal blood flow increase — vasodilatory effects in colonic vasculature.
No critical interactions identified.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.